Inspire Medical Systems, Inc. (INSP) Stock Analysis & Investment Frameworks
Inspire Medical Systems, Inc. (INSP) stock analysis on Invetso. Review Inspire Medical Systems, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Inspire Medical Systems, Inc. Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Inspire Medical Systems, Inc. Key Financial Metrics
- Market Cap: $1.85B
- Revenue: $911.98M
- P/E Ratio: 12.75
- ROE: 12.49%
- ROIC: 1.84%
- Dividend Yield: N/A
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.